ERO1A and breast cancer: Endoplasmic reticulum disulphide oxidase 1-α (ERO1-α) is highly overexpressed in triple-negative breast cancer, including the MDA-MB-231 cell line, and constitutes a marker of poor prognosis in breast cancer [64,65].